Pharmaniaga Bhd has secured a RM281.67 million contract to supply medical products to the Malaysian government through the Health Ministry’s (MoH) tender procurement exercise.
In a filing with Bursa Malaysia, the pharmaceutical company said the contract was awarded to its wholly-owned subsidiary, Pharmaniaga Lifescience Sdn Bhd (PLS).
The contract will run for a three-year period from June 3, 2026 to June 2, 2029.
Pharmaniaga said the agreement falls within the ordinary course of business of the group and will allow PLS to continue providing distribution services for the supply of medical products to the MoH.
The company added that the contract also supports efforts to improve diabetes management in Malaysia through the supply of high-quality and cost-effective biosimilar insulin products, amid the growing number of diabetic patients nationwide.
Pharmaniaga expects the contract to contribute positively to the group’s earnings throughout the contract duration ending in 2029.
